Next Article in Journal
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
Next Article in Special Issue
The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells
Previous Article in Journal
Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line
Previous Article in Special Issue
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(2), 256; https://doi.org/10.3390/pharmaceutics14020256
Action Date Notes Link
article pdf uploaded. 21 January 2022 21:03 CET Version of Record https://www.mdpi.com/1999-4923/14/2/256/pdf-vor
article xml file uploaded 28 January 2022 08:58 CET Original file -
article xml uploaded. 28 January 2022 08:58 CET Update https://www.mdpi.com/1999-4923/14/2/256/xml
article pdf uploaded. 28 January 2022 08:58 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/256/pdf
article html file updated 28 January 2022 09:00 CET Original file -
article html file updated 28 January 2022 09:00 CET Update -
article html file updated 28 January 2022 09:01 CET Update -
article html file updated 28 January 2022 09:58 CET Update -
article html file updated 31 July 2022 05:21 CEST Update https://www.mdpi.com/1999-4923/14/2/256/html
Back to TopTop